Subscribe to stay informed!
Berwyn-based Annovis Bio is delaying the release of the late-stage study results of its experimental Parkinson’s disease treatment, writes John George for…
While biotech is a tough line of work that has a historically high percentage of companies whose stock trades at or below their cash value…
Annovis Bio, a Berwyn-based biotech company, has managed to raise $8.7 million to advance its experimental treatment for Parkinson’s and Alzheimer’s…
Before we send you to this site, please subscribe to our daily newsletter.